Ouverture: | - |
Variation: | - |
Volume: | - |
+ Bas: | - |
+ Haut: | - |
Ecart + Bas / + Haut: | - |
Type: | Actions |
Ticker: | ALERS |
ISIN: | FR0013240934 |
EUROBIO SCIENTIFIC LAUNCHES THE EXCLUSIVE DISTRIBUTION OF THE FIRST SALIVA SELF-TEST FOR HIV TESTING IN FRANCE
- 88
EUROBIO SCIENTIFIC LAUNCHES THE EXCLUSIVE DISTRIBUTION OF
THE FIRST SALIVA SELF-TEST FOR HIV TESTING IN FRANCE
OraQuick®: first rapid saliva self-test for HIV screening for point-of-care biology, including pharmacies
Paris, January 11, 2022 – 5:45pm
Eurobio Scientific (FR0013240934, ALERS, eligible PEA-PME), a leading French group in specialty in vitro medical diagnostics, announces that it entered into an exclusive distribution contract for the commercialization of OraQuick®, a saliva self-test, with Orasure, a US company. This exclusive contract includes the French market and its overseas territories.
OraQuick® is a CE marked rapid test that can detect the presence of antibodies characteristic of HIV infections in 20 minutes from a saliva sample. Like the COVID serological tests, it includes a small plate with a window to view the result. It does not require a blood sample but a simple saliva sample drawn with a palette also provided for this purpose.
In France, an estimated 173,000 people are infected with HIV, 24,000 of whom are unaware of their infection. Currently, more than 25% of HIV tests are carried out on late stage infections. The availability of rapid screening tests that are easy to implement is therefore essential to encourage self-screening in all discretion.
OraQuick® is immediately available in pharmacies and for hospital or non-profit organizations screening centers. With this test, Eurobio Scientific is strengthening its presence in point-of-care biology, particularly in pharmacies, and expanding its range of self-tests, its COVID self-test being already available since June 2021.
Next financial meeting
2021 FY revenues: 24 January 2022
Attachment
GlobeNewswire est l'un des plus grands réseaux de distribution de nouvelles au monde, spécialisé dans la diffusion de communiqués de presse, d'informations financières et de contenus multimédias aux investisseurs, médias, et lecteurs du monde entier.